Trial Profile
Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β-cell protection in individuals with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2010
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin suspension isophane; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 05 Jun 2009 Results presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA 2009).
- 05 Jun 2009 New trial record